CD9 and neuroblastoma: Combined treatment of BE(2)-C and SH-EP neuroblastoma cells with panobinostat and DAC synergistically induced CD9 up to 8-fold on the transcript and 6.5-fold on the protein levels (Figure 5G-5H).